Literature DB >> 27979911

Atrioventricular Node Dysfunction and Ion Channel Transcriptome in Pulmonary Hypertension.

Ian P Temple1, Sunil Jit R J Logantha1, Mais Absi1, Yu Zhang1, Eleftheria Pervolaraki1, Joseph Yanni1, Andrew Atkinson1, Maria Petkova1, Gillian M Quigley1, Simon Castro1, Mark Drinkhill1, Heiko Schneider1, Oliver Monfredi1, Elizabeth Cartwright1, Min Zi1, Tomoko T Yamanushi1, Vaikom S Mahadevan1, Alison M Gurney1, Ed White1, Henggui Zhang1, George Hart1, Mark R Boyett2, Halina Dobrzynski1.   

Abstract

BACKGROUND: Heart block is associated with pulmonary hypertension, and the aim of the study was to test the hypothesis that the heart block is the result of a change in the ion channel transcriptome of the atrioventricular (AV) node. METHODS AND
RESULTS: The most commonly used animal model of pulmonary hypertension, the monocrotaline-injected rat, was used. The functional consequences of monocrotaline injection were determined by echocardiography, ECG recording, and electrophysiological experiments on the Langendorff-perfused heart and isolated AV node. The ion channel transcriptome was measured by quantitative PCR, and biophysically detailed computer modeling was used to explore the changes observed. After monocrotaline injection, echocardiography revealed the pattern of pulmonary artery blood flow characteristic of pulmonary hypertension and right-sided hypertrophy and failure; the Langendorff-perfused heart and isolated AV node revealed dysfunction of the AV node (eg, 50% incidence of heart block in isolated AV node); and quantitative PCR revealed a widespread downregulation of ion channel and related genes in the AV node (eg, >50% downregulation of Cav1.2/3 and HCN1/2/4 channels). Computer modeling predicted that the changes in the transcriptome if translated into protein and function would result in heart block.
CONCLUSIONS: Pulmonary hypertension results in a derangement of the ion channel transcriptome in the AV node, and this is the likely cause of AV node dysfunction in this disease.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atrioventricular node; echocardiography; heart block; ion channels; transcriptome

Mesh:

Substances:

Year:  2016        PMID: 27979911      PMCID: PMC5679363          DOI: 10.1161/CIRCEP.115.003432

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  39 in total

1.  Sympatholysis and cardiac sympathetic nerve function in the treatment of congestive heart failure.

Authors:  Chang-seng Liang
Journal:  J Am Coll Cardiol       Date:  2003-08-06       Impact factor: 24.094

2.  Novel method to assess cardiac electrophysiology in the rat: characterization of standard ion channel blockers.

Authors:  Christopher P Regan; Hillary K Cresswell; Rena Zhang; Joseph J Lynch
Journal:  J Cardiovasc Pharmacol       Date:  2005-07       Impact factor: 3.105

3.  Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.

Authors:  David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

4.  Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

Authors:  David Benoist; Rachel Stones; Mark Drinkhill; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-11       Impact factor: 4.733

5.  Cardiac arrhythmia induction after exposure to residual oil fly ash particles in a rodent model of pulmonary hypertension.

Authors:  W P Watkinson; M J Campen; D L Costa
Journal:  Toxicol Sci       Date:  1998-02       Impact factor: 4.849

6.  Cardiac beta-adrenoceptor changes in monocrotaline-treated rats: differences between membrane preparations from whole ventricles and isolated ventricular cardiomyocytes.

Authors:  Kirsten Leineweber; Torsten Seyfarth; Getu Abraham; Hans-Peter Gerbershagen; Ingrid Heinroth-Hoffmann; Klaus Pönicke; Otto-Erich Brodde
Journal:  J Cardiovasc Pharmacol       Date:  2003-03       Impact factor: 3.105

Review 7.  Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues.

Authors:  Halina Dobrzynski; Robert H Anderson; Andrew Atkinson; Zoltan Borbas; Alicia D'Souza; John F Fraser; Shin Inada; Sunil J R J Logantha; Oliver Monfredi; Gwilym M Morris; Anton F M Moorman; Thodora Nikolaidou; Heiko Schneider; Viktoria Szuts; Ian P Temple; Joseph Yanni; Mark R Boyett
Journal:  Pharmacol Ther       Date:  2013-04-20       Impact factor: 12.310

8.  Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice.

Authors:  Jan Matthes; Leyla Yildirim; Georg Wietzorrek; Daniel Reimer; Jörg Striessnig; Stefan Herzig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-14       Impact factor: 3.000

9.  Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2009-11-05       Impact factor: 15.534

10.  Ion channel transcript expression at the rabbit atrioventricular conduction axis.

Authors:  Ian D Greener; James O Tellez; Halina Dobrzynski; Mitsuru Yamamoto; Gillian M Graham; Rudi Billeter; Mark R Boyett
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-04-02
View more
  8 in total

1.  Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.

Authors:  Benjamin Strauss; Yassine Sassi; Carlos Bueno-Beti; Zeki Ilkan; Nour Raad; Marine Cacheux; Malik Bisserier; Irene C Turnbull; Erik Kohlbrenner; Roger J Hajjar; Lahouaria Hadri; Fadi G Akar
Journal:  J Mol Cell Cardiol       Date:  2018-11-28       Impact factor: 5.000

Review 2.  Animal models of arrhythmia: classic electrophysiology to genetically modified large animals.

Authors:  Sebastian Clauss; Christina Bleyer; Dominik Schüttler; Philipp Tomsits; Simone Renner; Nikolai Klymiuk; Reza Wakili; Steffen Massberg; Eckhard Wolf; Stefan Kääb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

3.  Structural and functional remodeling of the atrioventricular node with aging in rats: The role of hyperpolarization-activated cyclic nucleotide-gated and ryanodine 2 channels.

Authors:  Yawer Saeed; Ian P Temple; Zoltan Borbas; Andrew Atkinson; Joseph Yanni; Michal Maczewski; Urszula Mackiewicz; Mariam Aly; Sunil Jit R J Logantha; Clifford J Garratt; Halina Dobrzynski
Journal:  Heart Rhythm       Date:  2017-12-27       Impact factor: 6.343

4.  Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension.

Authors:  Evandro M Neto-Neves; Andrea L Frump; Alexandra Vayl; Jeffrey A Kline; Tim Lahm
Journal:  Physiol Rep       Date:  2017-10-16

Review 5.  Importance of Cx43 for Right Ventricular Function.

Authors:  Kerstin Boengler; Susanne Rohrbach; Norbert Weissmann; Rainer Schulz
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

6.  Cardiac Pacemaker Dysfunction Arising From Different Studies of Ion Channel Remodeling in the Aging Rat Heart.

Authors:  Aaazh M Alghamdi; Mark R Boyett; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2020-12-03       Impact factor: 4.566

7.  Right Heart Failure in a Patient with Critical Pulmonary Stenosis, Absent Right Pulmonary Artery, and Lung Cancer.

Authors:  Arthur Iturriagagoitia; Marc Vanderheyden; Werner Budts; Piet Vercauter
Journal:  Am J Case Rep       Date:  2022-08-17

8.  Transcriptomic profile of cationic channels in human pulmonary arterial hypertension.

Authors:  Francisco Perez-Vizcaino; Angel Cogolludo; Gema Mondejar-Parreño
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.